Using beta-blockers lowers pain and opioid use among patients with symptomatic large joint osteoarthritis, according to a study in Arthritis Care and Research. Researchers assessed joint pain in 873 ...

MIAMI - A new use of a long-established drug helped prevent the searing pain of sickle cell anemia in hundreds of patients as young as 9 months in a national trial. Until now, the drug has been ...

Researchers from New York University and affiliated organizations have detailed data for C-2230, a Cav2.2 channel blocker being developed for the treatment of pain.

PHILADELPHIA -- An oral, non-addictive sodium channel blocker safely relieved moderate-to-severe acute pain following surgery, according to phase III data that could support regulatory approval.

Editor’s Note (1/31/25): The U.S. Food and Drug Administration has approved the novel nonopioid medication suzetrigine for acute pain. That pain ranges from moderate to severe. The drug was tested in ...